Matches in Wikidata for { <http://www.wikidata.org/entity/Q90566894> ?p ?o ?g. }
- Q90566894 description "article scientifique publié en 2018" @default.
- Q90566894 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90566894 description "scientific article published on 13 December 2018" @default.
- Q90566894 description "wetenschappelijk artikel" @default.
- Q90566894 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90566894 name "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 name "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 type Item @default.
- Q90566894 label "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 label "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 prefLabel "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 prefLabel "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 P1433 Q90566894-1D580B4D-17C7-4CF0-967C-2C41EC6F4AD0 @default.
- Q90566894 P1476 Q90566894-8340F309-3EAF-4351-B499-C9CE7604D9AB @default.
- Q90566894 P2093 Q90566894-1E1065FC-48EE-4692-84FE-68275B8C647A @default.
- Q90566894 P2093 Q90566894-297FBAD4-09C5-4E51-8E9D-D0BF888BB719 @default.
- Q90566894 P2093 Q90566894-31B7E763-8FBD-4FD4-B868-CFA214CF8794 @default.
- Q90566894 P2093 Q90566894-4E1D0E6E-0984-4A2C-B8F8-4BDA1D97310C @default.
- Q90566894 P2093 Q90566894-68868626-D66A-4ED1-B6F3-C6A726770512 @default.
- Q90566894 P2093 Q90566894-7E27DA82-CE0D-4F0C-97BF-4E36C182417E @default.
- Q90566894 P2093 Q90566894-8E126AE8-0BDA-4AF8-9795-D91F9ED8BDD2 @default.
- Q90566894 P2093 Q90566894-BB301533-222B-4562-AD02-41E9818DFC45 @default.
- Q90566894 P2093 Q90566894-DD22EF68-D573-4CF4-BBE9-150867617DF0 @default.
- Q90566894 P2093 Q90566894-E9DAE9D8-506A-4CB7-BA8C-E1C2EC479D4D @default.
- Q90566894 P2093 Q90566894-F6A61C75-E21C-4E86-939C-AFBFB1DF183E @default.
- Q90566894 P2860 Q90566894-037A813D-D4CE-4B2C-9B14-C44C43E68B74 @default.
- Q90566894 P2860 Q90566894-039F95BE-2AB8-4B49-BFE0-1330CFDC3DAD @default.
- Q90566894 P2860 Q90566894-060DF288-1B4C-498F-8A96-D917F4D1BC7B @default.
- Q90566894 P2860 Q90566894-0CA25FB3-3886-4276-816E-E143EA65F2C1 @default.
- Q90566894 P2860 Q90566894-1753279B-A5E7-4414-ADD3-E9DE60EF3930 @default.
- Q90566894 P2860 Q90566894-19E0F201-77A2-4D6F-A22F-6A6FB3B309B9 @default.
- Q90566894 P2860 Q90566894-23836B25-7B3D-48C0-9441-E0D6C8235FA7 @default.
- Q90566894 P2860 Q90566894-27CADAC7-5F20-4E74-A94A-1CCFF59E29A3 @default.
- Q90566894 P2860 Q90566894-28FA10FF-764F-4B8C-98B5-C09EBA935824 @default.
- Q90566894 P2860 Q90566894-2CBA9D26-019F-4200-B551-93C47E736FEC @default.
- Q90566894 P2860 Q90566894-348E89C1-EA21-46F8-91B4-36C7F863960C @default.
- Q90566894 P2860 Q90566894-4DF7FB6D-91CD-4965-A0E8-6213B802320B @default.
- Q90566894 P2860 Q90566894-4EB8A675-BEF4-4EAD-B3C3-170FD2D9683F @default.
- Q90566894 P2860 Q90566894-6A624341-37D8-4154-B70F-8E2CE98F5BD5 @default.
- Q90566894 P2860 Q90566894-7E2406AC-A556-45D6-A60D-A43DA6975294 @default.
- Q90566894 P2860 Q90566894-82985BEA-B1E3-4E87-A546-45FAECF0DDB9 @default.
- Q90566894 P2860 Q90566894-86E8780D-14EC-49D4-A197-F9BDDB747ED0 @default.
- Q90566894 P2860 Q90566894-930253A5-EB3E-4075-8BE6-00B2A2336088 @default.
- Q90566894 P2860 Q90566894-9869580A-44AA-4F52-8CEE-46C889D95561 @default.
- Q90566894 P2860 Q90566894-9E9D54C9-91FD-435C-925E-BF94B4C3EE6C @default.
- Q90566894 P2860 Q90566894-A7F17B12-E8AE-4A5D-91D4-4F4F86552BF3 @default.
- Q90566894 P2860 Q90566894-A9CB7BEE-82BA-4B22-9120-8555A83894B3 @default.
- Q90566894 P2860 Q90566894-B6E87BED-CA80-460A-806B-EEC5F41DE7F1 @default.
- Q90566894 P2860 Q90566894-B8EC1C98-E003-4C1D-B446-3D9A29312457 @default.
- Q90566894 P2860 Q90566894-BF76DA05-550A-408A-BCBF-F126ED7A556F @default.
- Q90566894 P2860 Q90566894-C138C7C4-1B11-4816-AB6E-E06C3E5C38D3 @default.
- Q90566894 P2860 Q90566894-CE135CA4-A8E9-4B82-ACE5-36167D0F9DCD @default.
- Q90566894 P2860 Q90566894-D3C04754-A8D1-45D4-8755-48EF8D032573 @default.
- Q90566894 P2860 Q90566894-D79058A1-96ED-4613-AC40-A64FE7AD9B20 @default.
- Q90566894 P2860 Q90566894-E4ECA101-9C44-4F99-9F3F-7702D72DA4A3 @default.
- Q90566894 P2860 Q90566894-E5874B8D-E83E-4F26-A917-1BF7EE9AAD86 @default.
- Q90566894 P2860 Q90566894-F66E332C-1069-4594-801C-ED94EDDE0ED5 @default.
- Q90566894 P304 Q90566894-BF7EB52E-E41F-4EBC-806D-13B0659493F6 @default.
- Q90566894 P31 Q90566894-AEC39C87-D2E1-4BED-81C7-F5DEF2B420DD @default.
- Q90566894 P356 Q90566894-1AE032C2-9059-4E67-B69C-51D689F159D8 @default.
- Q90566894 P433 Q90566894-27E0D9CD-0C7E-46A4-A6F1-F9E33F97369A @default.
- Q90566894 P478 Q90566894-29F1683A-81AC-4325-B30A-7EB7907D08DF @default.
- Q90566894 P50 Q90566894-4C100932-CB6D-4B3F-81B0-5381630462B3 @default.
- Q90566894 P577 Q90566894-7DD0FCA7-01D3-4067-8B87-09AE3AACDDBF @default.
- Q90566894 P698 Q90566894-F8780C41-7013-4259-85AB-7CCAEE075F94 @default.
- Q90566894 P921 Q90566894-269763E2-2693-43DF-A5FC-428EEEF75D38 @default.
- Q90566894 P921 Q90566894-BDA10DCB-2A36-4382-A935-5614C94D0DB6 @default.
- Q90566894 P356 S0140-6736(18)31785-9 @default.
- Q90566894 P698 30554783 @default.
- Q90566894 P1433 Q939416 @default.
- Q90566894 P1476 "Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial" @default.
- Q90566894 P2093 "Arun Sanyal" @default.
- Q90566894 P2093 "Brent A Neuschwander-Tetri" @default.
- Q90566894 P2093 "Dina Halegoua-DeMarzio" @default.
- Q90566894 P2093 "Edgar D Charles" @default.
- Q90566894 P2093 "Eric J Lawitz" @default.
- Q90566894 P2093 "Rohit Loomba" @default.
- Q90566894 P2093 "Rose Christian" @default.
- Q90566894 P2093 "Stephanie Noviello" @default.
- Q90566894 P2093 "Stephen A Harrison" @default.
- Q90566894 P2093 "Sudeep Kundu" @default.
- Q90566894 P2093 "Yi Luo" @default.
- Q90566894 P2860 Q28079900 @default.
- Q90566894 P2860 Q28263139 @default.
- Q90566894 P2860 Q28543721 @default.
- Q90566894 P2860 Q29614930 @default.
- Q90566894 P2860 Q33262505 @default.
- Q90566894 P2860 Q34467171 @default.
- Q90566894 P2860 Q34577053 @default.
- Q90566894 P2860 Q34805555 @default.
- Q90566894 P2860 Q35071055 @default.
- Q90566894 P2860 Q35096971 @default.
- Q90566894 P2860 Q35108391 @default.
- Q90566894 P2860 Q35779219 @default.
- Q90566894 P2860 Q35787865 @default.
- Q90566894 P2860 Q36105168 @default.
- Q90566894 P2860 Q36243635 @default.
- Q90566894 P2860 Q36633255 @default.
- Q90566894 P2860 Q37173770 @default.
- Q90566894 P2860 Q37736540 @default.